Murli Krishna Pharma Private Limited - Due diligence report

A 360° intelligence report on Murli Krishna Pharma: trust score, financial health, credit view, compliance, directors, growth and distress s…

2004-04-02 Pune, Maharashtra Active Unlisted Active Compliant
Share
Connect MCP
MK Murli Krishna Pharma Private Limited
Full Due-Diligence Report + Documents
  • Unlock all financial figures & 5-year trends
  • Full trust, health & credit-risk scores
  • Director details, charges & MCA documents
₹700 ₹449 Save ₹251 excl. GST
Or from ₹279/report with credits View credit packages
Company Credits – Starter
  • One credit unlocks this full due-diligence report
  • Use across any company’s report, anytime
  • Credits valid for 12 months
× ₹700 ₹279 = ₹2,790 60% off
Choose your own credit amount View credit packages

Murli Krishna Pharma — 360° Intelligence Report

Generated from MCA filings & public records
81/100
Trust Score
Low Risk

Murli Krishna Pharma is assessed as Low Risk with a Trust Score of 81/100. Murli Krishna Pharma is an active private limited indian non-government company incorporated in 2004, operating in the Pharma sector. The company has shown revenue growth across its recent filed years. It was profitable in its latest filed year. Based on MCA filings and public records, it currently shows a low compliance risk and low financial risk profile.

Report generated on 16 Aug 2026 from the latest processed filings. Murli Krishna Pharma Private Limited snapshot & full profile →

Financial Health › Strong
Overall Assessment CautionWeakNeutralGoodStrong Strong
Compliance › Strong

Automated indicators derived from public MCA / GST / EPFO records - not a credit rating, not investment, legal or financial advice. Spotted an inaccuracy? Report an error.

02

Score Card

Higher is safer · rule-based & explainable
Trust ScoreLow Risk
81/100
Overall counterparty trust - the headline number of this report.
Compliance ScoreLow Risk
75/100
Statutory standing - status, filings, auditor, MSME and litigation.
Financial Health ScoreLow Risk
75/100
Profitability, leverage and liquidity from filed statements.
Credit Risk ScoreModerate
60/100
Debt capacity, gearing and security cover for lenders.
Director Stability ScoreLow Risk
90/100
Board strength, DIN status, churn and network.
Growth ScoreLow Risk
75/100
Revenue, profit, asset and hiring momentum.
Distress ScoreLow Risk
75/100
Early-warning signals - higher means fewer warnings.
03

Financial Intelligence Dashboard

Standalone · 5 filed year(s)

Unlock the full 5-year financial dashboard with charts and year-wise figures.

Get full access

Scores and observations on this page are already computed from the real filings - only the underlying figures are locked.

04

Credit & Compliance Intelligence

Why the scores are what they are
Credit Risk Score: 60/100 Moderate
  • Liabilities ≈ 38% EBITDA - stretched.
  • Moderate gearing (D/E 1.42).
  • Profitable - internal accruals available.

Charges position: 7 open (81.98 cr) · 5 satisfied (13.76 cr).

Banking relationships (from registered charges)
LenderChargesAmount
Hdfc Bank Limited4 48.0 cr
Others3 48.0 cr
Bank Of Maharashtra3 48.0 cr
Axis Bank Limited1 48.0 cr
The Bank Of Maharashtra Limited1 48.0 cr
Compliance Score: 75/100 Low Risk
  • Company status is Active as per MCA.
  • Annual filings current (balance sheet Mar 2025).
  • Litigation present in 1 court forum(s).
  • 1 auditor resignation(s) filed - latest: ANPJ & CO. on 2020-11-18.
  • Delayed payments to MSME suppliers disclosed (348 disclosure(s)).
  • 1 active GST registration(s).
Legal cases on record (1)
05

Director Intelligence

Stability score: 90/100
NameDIN / PANDesignationAppointedTenureDIN status
NITHYAGOVIND 01234567 Director 01/04/2018 6 yrs Approved
SATYA RAMANI VADLAMANI 01234567 Director 01/04/2018 6 yrs Approved
Venkat Murli Krishna Vadlamani 01234567 Director 01/04/2018 6 yrs Approved
VIJAY SHASTRI KALYANASUNDARAM 01234567 Director 01/04/2018 6 yrs Approved
  • 4 directors on the board.
  • No disqualified or deactivated DINs.
  • 1 director exit(s) in the last 3 years.
  • Average tenure above 5 years.
Director & KMP remuneration (FY 2024)
NameDesignationTotal remuneration
A K SharmaManaging Director2.4 cr
R MehtaWhole-time Director1.6 cr
S IyerCFO95.0 L

Remuneration is disclosed in the latest annual return. Unlock full report

06

Ownership & Group Intelligence

As per FY 2025 annual return
Promoter holding
64.27%
Public / other holding
35.73%
Equity shares
12,45,67,890
Equity paid-up
124.5 cr
Promoters on record
4
Ultimate holding entity
-
Subsidiaries
-
Group entities
-
Capital events
15 allotment(s) · 16 transfer(s)

Promoters hold a majority stake - exact percentages are part of the full report.

Key managerial personnel: SATYA RAMANI VADLAMANI (Managing Director)

Full shareholding pattern, group structure & capital events →

07

Risk Intelligence Center

Growth 75 · Distress 75
Growth signals & trust indicators
Revenue acceleration: +2.1x over 4 year(s).
EPFO headcount growing - hiring signal.
Operating for 22+ years.
Active EPFO - real payroll on record.
Active GST registration(s).
Distress signals & risk flags
Revenue declined year-on-year.
7 open charge(s) registered - assets are encumbered.
1 auditor resignation(s) on record - review the stated reasons.
MSME payment delays disclosed - latest outstanding 1.77 cr.
1 court case(s) on record - see the legal section for details.
08

Stakeholder Verdicts

Vendor · Banker · Investor
Vendor due diligence77/100
Favourable indicators
Suitability as a supplier / customer counterparty.
  • Statutory record is clean.
  • 1 distress signal(s) - see Risk Center.
  • Financial filings available for verification.
Banker assessment68/100
Mixed indicators - deeper appraisal suggested
Indicative lending comfort for banks, NBFCs and trade credit.
  • Debt capacity assessed from filed statements.
  • 7 open charge(s) of 81.98 cr already registered.
  • Compliance record supports lending.
Investor view76/100
Positive growth indicators
Growth quality and scalability through an investor lens.
  • 2 growth signal(s) detected.
  • Margin and return trends computable from filings.
  • Management team looks stable.
09

MCA Filings & Events Timeline

Latest 15 events
31 Dec 2025
Last AGM held
Annual general meeting
22 Aug 2025
Charge created
Hdfc Bank Limited - 30.00 Lakh
31 Mar 2025
Latest balance sheet
Filed with ROC
02 Dec 2024
Director ceased
Venkat Murli Krishna Vadlamani
15 Jul 2024
Director appointed
Venkat Murli Krishna Vadlamani (Director)
28 Jun 2024
Charge created
Others - 10.00 cr
31 Mar 2024
Share transfer (FY 2024)
8000.00000000 shares to Satya Ramani Vadlamani
Share transfer (FY 2024)
42000.00000000 shares to Satya Ramani Vadlamani
Share transfer (FY 2024)
49308.00000000 shares to Satya Ramani Vadlamani
Share transfer (FY 2024)
49307.00000000 shares to Seetamahalaxmi Challa
Share transfer (FY 2024)
5.00000000 shares to Satya Ramani Vadlamani
04 Sep 2023
Charge created
Axis Bank Limited - 1.30 cr
09 May 2023
Charge created
Hdfc Bank Limited - 23.02 Lakh
31 Mar 2023
Share transfer (FY 2023)
326245.00000000 shares to India Life Sciences Fund III LLC
Share transfer (FY 2023)
25000.00000000 shares to Krishna Venkata Murli Vadlamani
10

Key Observations

Auto-generated from the data above
Revenue grew 24% over the last 4 financial year(s).
Net profit margin moved from 0.86 to 61%.
Debt-to-equity stands at 38% - manageable leverage.
Net worth is positive.
Compliance record is strong - status, filings and flags are clean.
4 active director(s) / partner(s); board looks stable and experienced.
1 active GST registration(s) indicate ongoing business operations.
EPFO-registered employer - verifiable payroll history exists.
Promoters hold a majority stake as per the FY 2025 annual return.
Director / KMP remuneration is disclosed in the latest annual return - exact figures available in the full report.
Capital has been raised through 15 security allotment(s) - amounts available in the full report.
11

Peers & Related Companies

Full peer comparison →
CompanyCINLocation
9M India Limited U33119CT2020PLC010346 Mana Camp, Chattisgarh, India
Mechemco Resins Private Limited U25209MH1994PTC079404 Mumbai-400013, Maharashtra, India
Makwell Organics Private Limited U24100MH1988PTC049205 Mumbai, Maharashtra, India
Valtris Specialty Chemicals India Private Limited U24233MH2014PTC255644 Mumbai, Maharashtra, India
Ghaziabad Organics Limited U15511DL1996PLC075204 Delhi, Delhi, India
Canton Laboratories Private Limited U24110GJ2005PTC045571 Vadodara, Gujarat, India
Lasa Supergenerics L24233MH2016PLC274202 Khed, Maharashtra, India
Sol L72900TG1998PLC030463 Hyderabad, Telangana, India
12

Who Uses This Report

CA · CS · Banker · Investor · Vendor
Chartered Accountants (CA)

Verify Murli Krishna Pharma before audits and certifications: compliance score 75/100, filing history, auditor history and charge records in one place - instead of pulling each MCA form separately.

Company Secretaries (CS)

Track statutory health of Murli Krishna Pharma: ACTIVE compliance status, annual-return recency, director DIN status, board churn and the events timeline - the inputs for secretarial audits and due-diligence certificates.

Bankers & NBFCs

Current banker verdict: Mixed indicators - deeper appraisal suggested. Credit risk score 60/100, existing charge position and lender relationships - a first-pass credit memo before formal appraisal.

Investors & Analysts

Investor view: Positive growth indicators. Growth score 75/100, margin trends, ownership structure and peer set for Murli Krishna Pharma - screening before a deeper diligence.

Vendors & Procurement Teams

Vendor verdict: Favourable indicators. Trust score 81/100, distress signals and MSME payment-delay disclosures - know whether Murli Krishna Pharma pays its suppliers before you extend credit terms.

Lawyers & Compliance Teams

Litigation footprint (1 case(s) on record), regulatory flags, charge documents trail and director networks for Murli Krishna Pharma - groundwork for KYC, onboarding and disputes.

13

Frequently Asked Questions

Is Murli Krishna Pharma an active company?

Murli Krishna Pharma has MCA status “Active” with a compliance score of 75/100 (Low Risk).

Is Murli Krishna Pharma financially healthy?

Murli Krishna Pharma has a Financial Health Score of 75/100 (Low Risk) based on its filed financial statements.

Should I do business with Murli Krishna Pharma?

Its overall Trust Score is 81/100 (Low Risk). Vendor verdict: Favourable indicators. Review the risk flags in the Risk Intelligence Center before deciding.

Who controls Murli Krishna Pharma?

Promoters hold a majority stake - exact percentages are in the full report. 4 active director(s) are on record.

Does Murli Krishna Pharma have loans or charges against its assets?

7 open charge(s) are registered against its assets, and 5 earlier charge(s) stand satisfied.

Is Murli Krishna Pharma up to date with its ROC filings?

Annual filings current (balance sheet Mar 2025). Overall compliance score: 75/100 (Low Risk).

Is it risky to lend to Murli Krishna Pharma?

Its Credit Risk Score is 60/100 (Moderate). Banker verdict: Mixed indicators - deeper appraisal suggested.

Disclaimer: This report is generated automatically from MCA filings and public records as available in our system at the time of the last update. Scores, bands and verdicts are rule-based derived indicators of the underlying data - they are opinions generated by an algorithm, not statements of fact about the company, and are not credit ratings (within the meaning of SEBI regulations), audits, or investment, legal or financial advice. Verify from official sources and consult a qualified professional before any business, lending or investment decision. If you represent this company and believe any information is inaccurate or outdated, report it here and we will review promptly.